Literature DB >> 342616

Swine influenza virus infections in humans.

W R Dowdle, M A Hattwick.   

Abstract

Influenza in swine was first recognized as an epizootic disease in 1918. During that same year influenza virus in humans caused the worst pandemic on record. The virus of swine influenza was isolated in 1930. Swine influenza virus was first isolated from humans in 1974. Since then, including the cases at Fort Dix, there have been a total of nine viral isolations from humans in the United States. Serologic evidence of infections with swine influenza virus in humans has also been obtained. Evidence for transmission of swine influenza virus to humans before 1974 is minimal and circumstantial. Recent recognition of infections with swine influenza virus may be the result of better surveillance, increased numbers of susceptible humans, or increased viral infectivity for humans. Nevertheless, the apparent frequency of human infections and the declining levels of antibodies to swine influenza virus in the human population suggest that influenza viruses of swine may be a potential sources of epidemic disease for humans.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 342616     DOI: 10.1093/infdis/136.supplement_3.s386

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Real-time reverse transcription PCR for detection and quantitative analysis of equine influenza virus.

Authors:  Michelle Quinlivan; Eugene Dempsey; Fergus Ryan; Sean Arkins; Ann Cullinane
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 2.  Emerging respiratory viruses: challenges and vaccine strategies.

Authors:  Laura Gillim-Ross; Kanta Subbarao
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Effects of PB1-F2 on the pathogenicity of H1N1 swine influenza virus in mice and pigs.

Authors:  Jinhwa Lee; Jamie Henningson; Jingjiao Ma; Michael Duff; Yuekun Lang; Yonghai Li; Yuhao Li; Abdou Nagy; Sunyoung Sunwoo; Bhupinder Bawa; Jianmei Yang; Dingping Bai; Juergen A Richt; Wenjun Ma
Journal:  J Gen Virol       Date:  2017-01       Impact factor: 3.891

4.  Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.

Authors:  Ioanna Skountzou; Dimitrios G Koutsonanos; Jin Hyang Kim; Ryan Powers; Lakshmipriyadarshini Satyabhama; Feda Masseoud; William C Weldon; Maria Del Pilar Martin; Robert S Mittler; Richard Compans; Joshy Jacob
Journal:  J Immunol       Date:  2010-06-28       Impact factor: 5.422

5.  Genetic reassortment in pandemic and interpandemic influenza viruses. A study of 122 viruses infecting humans.

Authors:  L P Shu; G B Sharp; Y P Lin; E C Claas; S L Krauss; K F Shortridge; R G Webster
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 6.  Cases of swine influenza in humans: a review of the literature.

Authors:  Kendall P Myers; Christopher W Olsen; Gregory C Gray
Journal:  Clin Infect Dis       Date:  2007-03-06       Impact factor: 9.079

7.  Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries.

Authors:  Nancy F Crum-Cianflone; Patrick J Blair; Dennis Faix; John Arnold; Sara Echols; Sterling S Sherman; John E Tueller; Tyler Warkentien; Gabriela Sanguineti; Mary Bavaro; Braden R Hale
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

8.  Reflections on the 1976 swine flu vaccination program.

Authors:  David J Sencer; J Donald Millar
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

9.  Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin.

Authors:  Alexandra P Newman; Erik Reisdorf; Jeanne Beinemann; Timothy M Uyeki; Amanda Balish; Bo Shu; Stephen Lindstrom; Jenna Achenbach; Catherine Smith; Jeffrey P Davis
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

10.  Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.

Authors:  Xiaoqing Liu; Yuan Liu; Yanjun Zhang; Zhihui Chen; Ziwei Tang; Qingqiang Xu; Yue Wang; Ping Zhao; Zhongtian Qi
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.